Literature DB >> 738430

Migration of lymphoid cells to the bone marrow of rat following eradication of cells in DNA synthesis and in mitosis.

Z Ben-Ishay, F Reichert, S Sharon.   

Abstract

Eradication of replicating bone marrow cells of rat by means of combined administration of single doses of hydroxyurea and vinblastin is followed within 9--10 h by an inflow of lymphoid cells of extramedullary origin in the range of 13,200,000/femur. The rat bone marrow with a high content of lymphoid cells was previously shown to be concentrated in stem cells. The factor(s) which convey the 'information' of decrease of replicating marrow cells to extramedullary sites is at present unknown.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738430     DOI: 10.1007/bf01981479

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  5 in total

1.  Hydroxyurea-induced erythroid differentiation.

Authors:  N J Rencricca; B S Morse; F C Monette; D Howard; F Stohlman
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

2.  The lymphoid bone marrow. An experimental model.

Authors:  Z Ben-Ishay
Journal:  Isr J Med Sci       Date:  1975-10

3.  Selective eradication of rat bone marrow erythroid cells by administration of cytosine arabinoside. Observations on resumption phase of erythropoiesis.

Authors:  Z Ben-Ishay
Journal:  Scand J Haematol       Date:  1975-06

4.  Effects of hydroxyurea pretreatment of donor rats on growth of haematopoietic diffusion chamber colonies in mice.

Authors:  Z Ben-Ishay; S Sharon
Journal:  Scand J Haematol       Date:  1977-03

5.  Growth of diffusion chamber hematopoietic colonies derived from spleen cells of rats administered hydroxyurea.

Authors:  Z Ben-Ishay; S Sharon; F Reichert
Journal:  Acta Haematol       Date:  1978       Impact factor: 2.195

  5 in total
  1 in total

1.  Effect of hydroxyurea on two different types of hematopoietic stem cells (CFU-S and DCPC) of newborn mice.

Authors:  Z Ben-Ishay; G Prindull; D Ben-Israel
Journal:  Blut       Date:  1981-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.